Welcome to INDIVICON

As an association for individualised complementary oncology, our objective is to show new options for diagnosis and treatment in addition to the existing oncological diagnostics and therapy. In order to assure the qualified realisation of these new diagnoses and treatments, INDIVICON offers continuous professional development in this area through its regularly held training courses for members and interested physicians.

Especially for long term follow-up in oncology, members of INDIVICON can offer patients more certainty and safety by using e.g. a test for disseminated tumour cells in the blood or molecular tumour typing. Through an active support of the immune system, a positive influence on the further development of the pathogenesis can be exerted.

A co-operation between INDIVICON and the US-based diagnostics company Celera Diagnostics has led to the development of tests that enable the use of archived tumour tissue for an examination of treatment options. This can lead to valuable information for therapeutic decision making even years after having finished the hormone and chemotherapy as well as in case of a relapse of the tumour.

Celera Diagnostics bases its work on the knowledge acquired in decoding the human genome. In consequence, INDIVICON offers physicians as well as patients elaborate diagnostic options that can be used for the individual therapy of the patient.